{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T15:24:38Z","timestamp":1783178678739,"version":"3.54.6"},"reference-count":51,"publisher":"Japan Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1507\/endocrj.ej24-0584","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T22:16:04Z","timestamp":1738361764000},"page":"399-412","source":"Crossref","is-referenced-by-count":6,"title":["Clinicopathological and genomic analysis of pediatric pheochromocytoma and sympathetic paraganglioma"],"prefix":"10.1507","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8160-3687","authenticated-orcid":false,"given":"Noriko","family":"Kimura","sequence":"first","affiliation":[{"name":"Department of Clinical Research, and Department of Diagnostic Pathology, National Hospital Organization Hakodate Medical Center, Hakodate 041-8512, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1810-9894","authenticated-orcid":false,"given":"Koji","family":"Muroya","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kanagawa Children\u2019s Medical Center, Yokohama 232-8555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Yonamine","sequence":"additional","affiliation":[{"name":"Laboratory of Laboratory\/Sports Medicine, Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba 305-8575, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Takekoshi","sequence":"additional","affiliation":[{"name":"Laboratory of Laboratory\/Sports Medicine, Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba 305-8575, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0535-2975","authenticated-orcid":false,"given":"Takeshi","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Keio University School of Medicine, Tokyo 160-8582, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2998-7656","authenticated-orcid":false,"given":"Rei","family":"Hirose","sequence":"additional","affiliation":[{"name":"Endocrinology and Diabetes Center, Yokohama Rosai Hospital, Yokohama 222-0036, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8936-932X","authenticated-orcid":false,"given":"Takato","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery, Faculty of Medicine, University of Tsukuba, Tsukuba 305-8575, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kana","family":"Tamai","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Faculty of Medicine, University of Tsukuba, Tsukuba 305-8575, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyo","family":"Mabe","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Kumamoto University, Kumamoto 860-8556 Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2754-4182","authenticated-orcid":false,"given":"Junji","family":"Kawashima","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto 860-8556, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromichi","family":"Kijima","sequence":"additional","affiliation":[{"name":"Department of Diabetology and Endocrinology, Tonan Hospital, Sapporo 060-0004, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6083-6895","authenticated-orcid":false,"given":"Yuki","family":"Naruke","sequence":"additional","affiliation":[{"name":"Department of Pathology, Chiba Children\u2019s Hospital, Chiba 266-0007, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0396-8645","authenticated-orcid":false,"given":"Takuyuki","family":"Katabami","sequence":"additional","affiliation":[{"name":"Department of Metabolism and Endocrinology, St. Marianna University Yokohama Seibu Hospital, Yokohama 241-0811, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1 Chen H, Sippel RS, O\u2019Dorisio MS, Vinik AI, Lloyd RV, et al. (2010) The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer. Pancreas 39: 775\u2013783.","DOI":"10.1097\/MPA.0b013e3181ebb4f0"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Barontini M, Levin G, Sanso G (2006) Characteristics of pheochromocytoma in a 4- to 20-year-old population. Ann N Y Acad Sci 1073: 30\u201337.","DOI":"10.1196\/annals.1353.003"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 de Tersant M, G\u00e9n\u00e9r\u00e9 L, Frey\u00e7on C, Villebasse S, Abbas R, et al. (2020) Pheochromocytoma and paraganglioma in children and adolescents: Experience of the French Society of Pediatric Oncology (SFCE). J Endocr Soc 4: bvaa039.","DOI":"10.1210\/jendso\/bvaa039"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Virgone C, Andreetta M, Avanzini S, Chiaravalli S, De Pasquale D, et al. (2020) Pheochromocytomas and paragangliomas in children: Data from the Italian cooperative study (TREP). Pediatr Blood Cancer 67: e28332.","DOI":"10.1002\/pbc.28332"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Mannelli M, Castellano M, Schiavi F, Filetti S, Giacch\u00e8 M, et al. (2009) Clinically guided genetic screening in a large cohort of italian patients with pheochromocytomas and\/or functional or nonfunctional paragangliomas. J Clin Endocrinol Metab 94: 1541\u20131547.","DOI":"10.1210\/jc.2008-2419"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Bausch B, Wellner U, Bausch D, Schiavi F, Barontini M, et al. (2014) Long-term prognosis of patients with pediatric pheochromocytoma. Endocr Relat Cancer 21: 17\u201325.","DOI":"10.1530\/ERC-13-0415"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Bholah R, Bunchman TE (2017) Review of pediatric pheochromocytoma and paraganglioma. Front Pediatr 5: 155.","DOI":"10.3389\/fped.2017.00155"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Dahia PL (2014) Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity. Nat Rev Cancer 14: 108\u2013119.","DOI":"10.1038\/nrc3648"},{"key":"9","unstructured":"9 Kimura N, Capella C, Gill A, Komminoth P, Lam AKY, et al. (2017) Carotid body paraganglioma. In: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ (eds) WHO classification of head and neck tumours (4th). IARC, Lyon, France: 277\u2013280."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Stackpole RH, Melicow MM, Uson AC (1963) Pheochromocytoma in children. Report of 9 case and review of the first 100 published cases with follow-up studies. J Pediatr 63: 314\u2013330.","DOI":"10.1016\/S0022-3476(63)80345-5"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 King KS, Prodanov T, Kantorovich V, Fojo T, Hewitt JK, et al. (2011) Metastatic pheochromocytoma\/paraganglioma related to primary tumor development in childhood or adolescence: significant link to SDHB mutations. J Clin Oncol 29: 4137\u20134142.","DOI":"10.1200\/JCO.2011.34.6353"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Kuo MJM, Nazari MA, Jha A, Pacak K (2022) Pediatric metastatic pheochromocytoma and paraganglioma: clinical presentation and diagnosis, genetics, and therapeutic approaches. Front Endocrinol (Lausanne) 13: 936178.","DOI":"10.3389\/fendo.2022.936178"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Pinato DJ, Ramachandran R, Toussi ST, Vergine M, Ngo N, et al. (2013) Immunohistochemical markers of the hypoxic response can identify malignancy in phaeochromocytomas and paragangliomas and optimize the detection of tumours with VHL germline mutations. Br J Cancer 108: 429\u2013437.","DOI":"10.1038\/bjc.2012.538"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Favier J, Meatchi T, Robidel E, Badoual C, Sibony M, et al. (2020) Carbonic anhydrase 9 immunohistochemistry as a tool to predict or validate germline and somatic VHL mutations in pheochromocytoma and paraganglioma-a retrospective and prospective study. Mod Pathol 33: 57\u201364.","DOI":"10.1038\/s41379-019-0343-4"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 van Nederveen FH, Gaal J, Favier J, Korpershoek E, Oldenburg RA, et al. (2009) An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis. Lancet Oncol 10: 764\u2013771.","DOI":"10.1016\/S1470-2045(09)70164-0"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Gill AJ, Benn DE, Chou A, Clarkson A, Muljono A, et al. (2010) Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes. Hum Pathol 41: 805\u2013814.","DOI":"10.1016\/j.humpath.2009.12.005"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Burnichon N, Casc\u00f3n A, Schiavi F, Morales NP, Comino-M\u00e9ndez I, et al. (2012) MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma. Clin Cancer Res 18: 2828\u20132837.","DOI":"10.1158\/1078-0432.CCR-12-0160"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Fischer A, Kloos S, Maccio U, Friemel J, Remde H, et al. (2023) Metastatic pheochromocytoma and paraganglioma: somatostatin receptor 2 expression, genetics, and therapeutic responses. J Clin Endocrinol Metab 108: 2676\u20132685.","DOI":"10.1210\/clinem\/dgad166"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Kimura N, Takayanagi R, Takizawa N, Itagaki E, Katabami T, et al. (2014) Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma. Endocr Relat Cancer 21: 405\u2013414.","DOI":"10.1530\/ERC-13-0494"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Yonamine M, Wasano K, Aita Y, Sugasawa T, Takahashi K, et al. (2021) Prevalence of germline variants in a large cohort of Japanese patients with pheochromocytoma and\/or paraganglioma. Cancers (Basel) 13: 4014.","DOI":"10.3390\/cancers13164014"},{"key":"21","unstructured":"21 Muroya K (2019) Clinical and molecular genetic features of childhood-onset pheochromocytoma and paraganglioma. Program of endocrinology diabetes and global exchange in Japan (handout). Sandoz Pharmaceutical Company (In Japanese)."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Kimura N (2021) Dopamine \u03b2-hydroxylase: an essential and optimal immunohistochemical marker for pheochromocytoma and sympathetic paraganglioma. Endocr Pathol 32: 258\u2013261.","DOI":"10.1007\/s12022-020-09655-w"},{"key":"23","unstructured":"23 Kimura N, Pilichowska M, Date F, Kimura I, Schindler M (1999) Immunohistochemical expression of somatostatin type 2A receptor in neuroendocrine tumors. Clin Cancer Res 5: 3483\u20133487."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Kimura N, Schindler M, Kasai N, Kimura I (2001) Immunohistochemical localization of somatostatin receptor type 2A in rat and human tissues. Endocr J 48: 95\u2013102.","DOI":"10.1507\/endocrj.48.95"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Kubo K, Kimura N, Watanabe R, Higashino M, Kato M (2022) Primary duodenal adenocarcinoma expressing carbonic anhydrase IX. Case Rep Gastroenterol 16: 308\u2013312.","DOI":"10.1159\/000524727"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Volante M, Brizzi MP, Faggiano A, La Rosa S, Rapa I, et al. (2007) Somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors: a proposal of scoring system correlated with somatostatin receptor scintigraphy. Mod Pathol 20: 1172\u20131182.","DOI":"10.1038\/modpathol.3800954"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Romanet P, Guerin C, Pedini P, Essamet W, Castinetti F, et al. (2017) Pathological and genetic characterization of bilateral adrenomedullary hyperplasia in a patient with germline MAX mutation. Endocr Pathol 28: 302\u2013307.","DOI":"10.1007\/s12022-016-9460-5"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Wachtel H, Hutchens T, Baraban E, Schwartz LE, Montone K, et al. (2020) Predicting metastatic potential in pheochromocytoma and paraganglioma: a comparison of PASS and GAPP scoring systems. J Clin Endocrinol Metab 105: e4661\u20134670.","DOI":"10.1210\/clinem\/dgaa608"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Koh JM, Ahn SH, Kim H, Kim BJ, Sung TY, et al. (2017) Validation of pathological grading systems for predicting metastatic potential in pheochromocytoma and paraganglioma. PLoS One 12: e0187398.","DOI":"10.1371\/journal.pone.0187398"},{"key":"30","unstructured":"30 Sasaki T, Masumoto K, Shinkai T, Gotoh C, Urita Y, et al. (2014) Partial adrenalectomy to preserve adrenal function in bilateral adrenal pheochromocytoma with von-Hipple-Lindau disease: a case report. J Jpn Soc Pediatr Surg 50: 910\u2013915 (Abstract in English)."},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Imamura H, Muroya K, Tanaka E, Konomoto T, Moritake H, et al. (2016) Sporadic paraganglioma caused by de novo SDHB mutations in a 6-year-old girl. Eur J Pediatr 175: 137\u2013141.","DOI":"10.1007\/s00431-015-2614-5"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Hirose R, Tsurutani Y, Sugisawa C, Inoue K, Suematsu S, et al. (2021) Hereditary pheochromocytoma\/paraganglioma syndrome with a novel mutation in the succinate dehydrogenase subunit B gene in a Japanese family: two case reports. J Med Case Rep 15: 282.","DOI":"10.1186\/s13256-021-02852-z"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Lack EE (2007) Extraadrenal paraganglia, paragangliomas, and other features of sympathoadrenal paragangliomas. In: Lack EE (ed) Tumors of the adrenal glands and extraadrenal paraganglia. AFIP atlas of tumor pathology (4th). American Registry of Pathology, Washington DC, USA: 283\u2013322.","DOI":"10.55418\/9781881041016-11"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Kimura N, Takekoshi K, Horii A, Morimoto R, Imai T, et al. (2014) Clinicopathological study of SDHB mutation-related pheochromocytoma and sympathetic paraganglioma. Endocr Relat Cancer 21: L13\u2013L16.","DOI":"10.1530\/ERC-13-0530"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Kubo H, Tsurutani Y, Sunouchi T, Hoshino Y, Hirose R, et al. (2022) A case of (123)I-metaiodobenzylguanidine scintigraphy-negative pheochromocytoma with a tumor-developing mutation in the RET gene. J Clin Med 11: 4624.","DOI":"10.3390\/jcm11154624"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Favier J, Amar L, Gimenez-Roqueplo AP (2015) Paraganglioma and phaeochromocytoma: from genetics to personalized medicine. Nat Rev Endocrinol 11: 101\u2013111.","DOI":"10.1038\/nrendo.2014.188"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Curr\u00e1s-Freixes M, Inglada-P\u00e9rez L, Mancikova V, Montero-Conde C, Let\u00f3n R, et al. (2015) Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients. J Med Genet 52: 647\u2013656.","DOI":"10.1136\/jmedgenet-2015-103218"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Dahia PL (2006) Transcription association of VHL and SDH mutations link hypoxia and oxidoreductase signals in pheochromocytomas. Ann N Y Acad Sci 1073: 208\u2013220.","DOI":"10.1196\/annals.1353.023"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Burnichon N, Rohmer V, Amar L, Herman P, Leboulleux S, et al. (2009) The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas. J Clin Endocrinol Metab 94: 2817\u20132827.","DOI":"10.1210\/jc.2008-2504"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Rooijens PP, de Krijger RR, Bonjer HJ, van der Ham F, Nigg AL, et al. (2004) The significance of angiogenesis in malignant pheochromocytomas. Endocr Pathol 15: 39\u201345.","DOI":"10.1385\/EP:15:1:39"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 Favier J, Plouin PF, Corvol P, Gasc JM (2002) Angiogenesis and vascular architecture in pheochromocytomas: distinctive traits in malignant tumors. Am J Pathol 161: 1235\u20131246.","DOI":"10.1016\/S0002-9440(10)64400-8"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42 Oudijk L, van Nederveen F, Badoual C, Tissier F, Tischler AS, et al. (2015) Vascular pattern analysis for the prediction of clinical behaviour in pheochromocytomas and paragangliomas. PLoS One 10: e0121361.","DOI":"10.1371\/journal.pone.0121361"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43 Gao X, Yamazaki Y, Pecori A, Tezuka Y, Ono Y, et al. (2020) Histopathological Analysis of Tumor Microenvironment and Angiogenesis in Pheochromocytoma. Front Endocrinol (Lausanne) 11: 587779.","DOI":"10.3389\/fendo.2020.587779"},{"key":"44","unstructured":"44 Unger P, Hoffman K, Pertsemlidis D, Thung S, Wolfe D, et al. (1991) S100 protein-positive sustentacular cells in malignant and locally aggressive adrenal pheochromocytomas. Arch Pathol Lab Med 115: 484\u2013487."},{"key":"45","unstructured":"45 Jimenez C, Libutti SK, Landry CS, Lloyd RV, McKay RR, et al. (2017) Adrenal-neuroendocrine tumors. In: Amin MB (ed) AJCC Cancer Staging Manual (8th). Springer, Cham, Switzerland: 919\u2013927."},{"key":"46","unstructured":"46 Tischler AS, de Krijer RR, Gill A, Kawashima A, Kimura N, et al. (2017) Pheochromocytoma. In: Lloyd RV, Osamura RY, Kloppel G, Rosai J (eds) WHO Classification of Tumours of Endocrine Organs (4th). IARC, Lyon, France: 181\u2013189."},{"key":"47","doi-asserted-by":"crossref","unstructured":"47 D\u00e4rr R, Nambuba J, Del Rivero J, Janssen I, Merino M, et al. (2016) Novel insights into the polycythemia-paraganglioma-somatostatinoma syndrome. Endocr Relat Cancer 23: 899\u2013908.","DOI":"10.1530\/ERC-16-0231"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48 Ladroue C, Carcenac R, Leporrier M, Gad S, Le Hello C, et al. (2008) PHD2 mutation and congenital erythrocytosis with paraganglioma. N Engl J Med 359: 2685\u20132692.","DOI":"10.1056\/NEJMoa0806277"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49 Yang C, Zhuang Z, Fliedner SM, Shankavaram U, Sun MG, et al. (2015) Germ-line PHD1 and PHD2 mutations detected in patients with pheochromocytoma\/paraganglioma-polycythemia. J Mol Med (Berl) 93: 93\u2013104.","DOI":"10.1007\/s00109-014-1205-7"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50 Bayley JP, Bausch B, Jansen JC, Hensen EF, van der Tuin K, et al. (2023) SDHB variant type impacts phenotype and malignancy in pheochromocytoma-paraganglioma. J Med Genet 60: 25\u201332.","DOI":"10.1136\/jmedgenet-2020-107656"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51 Elston MS, Meyer-Rochow GY, Conaglen HM, Clarkson A, Clifton-Bligh RJ, et al. (2015) Increased SSTR2A and SSTR3 expression in succinate dehydrogenase-deficient pheochromocytomas and paragangliomas. Hum Pathol 46: 390\u2013396.","DOI":"10.1016\/j.humpath.2014.11.012"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/72\/4\/72_EJ24-0584\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T04:24:12Z","timestamp":1743827052000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/72\/4\/72_EJ24-0584\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej24-0584","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"EJ24-0584"}}